
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies is well-positioned to disrupt the medical market with their strong manufacturing capabilities, partnerships, and development of patient-specific implants using AI and additive manufacturing. With a new President onboard and a focus on expanding into the antimicrobial market, the company has a diverse portfolio and strong financial position to reach their goals by 2025/26. However, competition and slow adoption by surgeons may pose challenges for the company's success.
Bears say
SINTX Technologies is an innovative company with promising technology, but the high level of competition and the company's dependence on external financing and strategic partnerships pose significant risks to its profitability and growth potential. Additionally, while the company has made progress in regulatory approvals and product launches, its financial data shows a significant operating and net loss, indicating potential financial instability. Furthermore, the recent leadership additions and acquisition may improve commercial capabilities, but significant milestones and market adoption remain uncertain, impacting our negative outlook.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares